Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Thyroid disease and pregnancy".)
International
●Thyroid hormones treatment for subclinical hypothyroidism – A clinical practice guideline (2019)
Canada
●Choosing Wisely Canada: Don't order thyroid function tests as screening for asymptomatic, low risk patients (updated 2021)
●Choosing Wisely Canada: Don't routinely test for anti-thyroid peroxidase antibodies (anti-TPO) (2020)
●Choosing Wisely Canada: Don't use free T4 or T3 to screen for hypothyroidism or to monitor and adjust levothyroxine (T4) dose in patients with known primary hypothyroidism, unless the patient has suspected or known pituitary or hypothalamic disease (updated 2020)
●Society of Obstetricians and Gynaecologists of Canada (SOGC): Committee opinion – Thyroid disease and infertility (2020)
●Canadian Task Force on Preventive Health Care (CTFPHC): Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care (2019)
United States
●American Thyroid Association (ATA), British Thyroid Association (BTA), and European Thyroid Association (ETA): Evidence-based use of levothyroxine/liothyronine combinations in treating hypothyroidism – A consensus document (2021)
●American College of Obstetricians and Gynecologists (ACOG): Practice bulletin on thyroid disease in pregnancy (2020)
●Choosing Wisely: Avoid Thyroid Stimulating Hormone (TSH) screening in annual well-visits for asymptomatic adults, regardless of age (2020)
●Choosing Wisely: Don't screen asymptomatic pregnant women for subclinical hypothyroidism (2019)
●ATA: Guidelines for the diagnosis and management of thyroid disease during pregnancy and the postpartum (2017)
●Choosing Wisely: Avoid routinely measuring thyroid function and/or insulin levels in children with obesity (2017)
●Choosing Wisely: Don't order a total or free T3 level when assessing levothyroxine (T4) dose in hypothyroid patients (2013, updated 2017)
●American Society for Reproductive Medicine (ASRM): Subclinical hypothyroidism in the infertile female population – A guideline (2015)
●Choosing Wisely: Don't order multiple tests in the initial evaluation of a patient with suspected thyroid disease. Order thyroid-stimulating hormone (TSH), and if abnormal, follow up with additional evaluation or treatment depending on the findings (2015)
●US Preventive Services Task Force (USPSTF): Final recommendation statement – Thyroid dysfunction: Statement (2015)
●ATA: Guidelines for the treatment of hypothyroidism (2014)
Europe
●American Thyroid Association (ATA), British Thyroid Association (BTA), and European Thyroid Association (ETA): Evidence-based use of levothyroxine/liothyronine combinations in treating hypothyroidism – A consensus document (2021)
●European Reference Network on Rare Endocrine Conditions (ENDO-ERN): Congenital hypothyroidism – A 2020-2021 consensus guidelines update (published 2021)
●ETA: Guideline on thyroid disorders prior to and during assisted reproduction (2021)
●ETA: Guidelines on the management of thyroid dysfunction following immune reconstitution therapy (2019)
●ETA: Guidelines for the management of amiodarone-associated thyroid dysfunction (2018)
●ETA: Guidelines on the diagnosis and management of central hypothyroidism (2018)
●ETA: Guidelines for the management of subclinical hypothyroidism in pregnancy and in children (2014)
●European Society for Paediatric Endocrinology (ESPE): Consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism (2014)
●ETA: Guideline – Management of subclinical hypothyroidism (2013)
●ETA: Guidelines – The use of L-T4 + L-T3 in the treatment of hypothyroidism (2012)
United Kingdom
●American Thyroid Association (ATA), British Thyroid Association (BTA), and European Thyroid Association (ETA): Evidence-based use of levothyroxine/liothyronine combinations in treating hypothyroidism – A consensus document (2021)
●National Institute for Health and Care Excellence (NICE): Guideline on thyroid disease – Assessment and management (2019)
●BTA: Statement for the management of primary hypothyroidism (2015)
India
●Federation of Obstetric & Gynecological Societies of Indian (FOGSI): Recommendations for the management of thyroid dysfunction in pregnancy (2019)
●Indian Society for Pediatric and Adolescent Endocrinology (ISPAE): Newborn screening guidelines for congenital hypothyroidism in India – Recommendations: Part I – Screening and confirmation of diagnosis (2018)
●ISPAE: Newborn screening guidelines for congenital hypothyroidism in India – Recommendations: Part II – Imaging, treatment and follow-ups (2018)
●Ministry of Health & Family Welfare (MHFW): National guidelines for screening of hypothyroidism during pregnancy (2014)
Australia-New Zealand
●Choosing Wisely Australia: Don't test thyroid function as population screening for asymptomatic patients (reviewed 2016)
●Choosing Wisely Australia: Don't order a total or free T3 level when assessing thyroxine dose in hypothyroid patients (reviewed 2015)
●Choosing Wisely Australia: Don't routinely order a thyroid ultrasound in patients with abnormal thyroid function tests if there is no palpable abnormality of the thyroid gland (reviewed 2015)
Japan
●[In Japanese] Japanese Society of Pediatric Endocrine (JSPE): Guidelines for mass screening of congenital hypothyroidism, revision (2014)
●[In English] Japan Thyroid Association (JTA): Guidelines for the diagnosis of hypothyroidism (2010)
